Hims & Hers Health is trading at €28.80, up +4.50%, while the immediate reason for the gain remains unclear.

  • No confirmed August 24, 2026 company-specific catalyst was identified.
  • Recent coverage highlighted wider losses from branded weight-loss investments alongside strong revenue growth.
  • The broader market was essentially unchanged; elevated activity followed the prior session’s unexplained advance.